This week, Hillary Clinton has dusted off one of the Democrats' favorite health care bogeymen — Big Pharma. But there's no data to support her claims that drug spending is out of control.
Read more at Investor's Business Daily
Tuesday, September 22, 2015
Hillary's drug price control plan is based on one big lie
Labels:
Big Pharma,
drugs,
Hillary Clinton,
R&D
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment